19-51225331-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001772.4(CD33):c.151G>A(p.Asp51Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000929 in 1,614,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001772.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD33 | NM_001772.4 | c.151G>A | p.Asp51Asn | missense_variant | 2/7 | ENST00000262262.5 | NP_001763.3 | |
LOC107985327 | XR_007067309.1 | n.232-30671C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD33 | ENST00000262262.5 | c.151G>A | p.Asp51Asn | missense_variant | 2/7 | 1 | NM_001772.4 | ENSP00000262262 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152122Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000139 AC: 35AN: 251474Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135914
GnomAD4 exome AF: 0.0000814 AC: 119AN: 1461842Hom.: 0 Cov.: 34 AF XY: 0.0000963 AC XY: 70AN XY: 727212
GnomAD4 genome AF: 0.000204 AC: 31AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74438
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2022 | The c.151G>A (p.D51N) alteration is located in exon 2 (coding exon 2) of the CD33 gene. This alteration results from a G to A substitution at nucleotide position 151, causing the aspartic acid (D) at amino acid position 51 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at